nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Tenderness—Gefitinib—lung cancer	0.0233	0.0243	CcSEcCtD
Bretylium—Rash macular—Paclitaxel—lung cancer	0.0172	0.0179	CcSEcCtD
Bretylium—Mood swings—Pemetrexed—lung cancer	0.0141	0.0146	CcSEcCtD
Bretylium—Tenderness—Erlotinib—lung cancer	0.0139	0.0145	CcSEcCtD
Bretylium—Angina pectoris—Pemetrexed—lung cancer	0.0125	0.013	CcSEcCtD
Bretylium—Bradycardia—Crizotinib—lung cancer	0.0114	0.0119	CcSEcCtD
Bretylium—Conjunctivitis—Pemetrexed—lung cancer	0.0111	0.0116	CcSEcCtD
Bretylium—Conjunctivitis—Gefitinib—lung cancer	0.0111	0.0115	CcSEcCtD
Bretylium—Tenderness—Gemcitabine—lung cancer	0.00968	0.0101	CcSEcCtD
Bretylium—Lethargy—Topotecan—lung cancer	0.0091	0.00947	CcSEcCtD
Bretylium—Tenderness—Cisplatin—lung cancer	0.00902	0.00939	CcSEcCtD
Bretylium—Syncope—Crizotinib—lung cancer	0.00878	0.00914	CcSEcCtD
Bretylium—Hiccups—Irinotecan—lung cancer	0.00867	0.00902	CcSEcCtD
Bretylium—Loss of consciousness—Crizotinib—lung cancer	0.0086	0.00895	CcSEcCtD
Bretylium—Tenderness—Paclitaxel—lung cancer	0.0081	0.00843	CcSEcCtD
Bretylium—Syncope—Pemetrexed—lung cancer	0.00802	0.00835	CcSEcCtD
Bretylium—Hiccups—Cisplatin—lung cancer	0.00787	0.00819	CcSEcCtD
Bretylium—Loss of consciousness—Pemetrexed—lung cancer	0.00786	0.00818	CcSEcCtD
Bretylium—Shock—Crizotinib—lung cancer	0.00786	0.00818	CcSEcCtD
Bretylium—Ventricular extrasystoles—Paclitaxel—lung cancer	0.00783	0.00815	CcSEcCtD
Bretylium—Lethargy—Vinorelbine—lung cancer	0.00779	0.0081	CcSEcCtD
Bretylium—Angina pectoris—Vinblastine—lung cancer	0.00773	0.00804	CcSEcCtD
Bretylium—Flushing—Teniposide—lung cancer	0.00773	0.00804	CcSEcCtD
Bretylium—Hypertension—Pemetrexed—lung cancer	0.00772	0.00804	CcSEcCtD
Bretylium—Shock—Pemetrexed—lung cancer	0.00718	0.00748	CcSEcCtD
Bretylium—Shock—Gefitinib—lung cancer	0.00714	0.00743	CcSEcCtD
Bretylium—Dyspnoea—Crizotinib—lung cancer	0.00712	0.00741	CcSEcCtD
Bretylium—ATP1A1—mammary gland—lung cancer	0.00671	0.171	CbGeAlD
Bretylium—Conjunctivitis—Erlotinib—lung cancer	0.00661	0.00688	CcSEcCtD
Bretylium—Dyspnoea—Pemetrexed—lung cancer	0.00651	0.00677	CcSEcCtD
Bretylium—Dyspnoea—Gefitinib—lung cancer	0.00647	0.00673	CcSEcCtD
Bretylium—Angina pectoris—Vinorelbine—lung cancer	0.00642	0.00668	CcSEcCtD
Bretylium—Lightheadedness—Paclitaxel—lung cancer	0.00632	0.00658	CcSEcCtD
Bretylium—Body temperature increased—Crizotinib—lung cancer	0.00632	0.00657	CcSEcCtD
Bretylium—Nasal congestion—Cisplatin—lung cancer	0.00627	0.00653	CcSEcCtD
Bretylium—Hypertension—Teniposide—lung cancer	0.00626	0.00651	CcSEcCtD
Bretylium—Gastrointestinal pain—Pemetrexed—lung cancer	0.00597	0.00621	CcSEcCtD
Bretylium—Confusional state—Teniposide—lung cancer	0.00596	0.00621	CcSEcCtD
Bretylium—Gastrointestinal pain—Gefitinib—lung cancer	0.00593	0.00617	CcSEcCtD
Bretylium—Abdominal pain—Pemetrexed—lung cancer	0.00577	0.00601	CcSEcCtD
Bretylium—Body temperature increased—Pemetrexed—lung cancer	0.00577	0.00601	CcSEcCtD
Bretylium—Orthostatic hypotension—Irinotecan—lung cancer	0.00575	0.00598	CcSEcCtD
Bretylium—Abdominal pain—Gefitinib—lung cancer	0.00573	0.00597	CcSEcCtD
Bretylium—Body temperature increased—Gefitinib—lung cancer	0.00573	0.00597	CcSEcCtD
Bretylium—Hyperhidrosis—Teniposide—lung cancer	0.00572	0.00595	CcSEcCtD
Bretylium—Nasal congestion—Paclitaxel—lung cancer	0.00563	0.00586	CcSEcCtD
Bretylium—Diarrhoea—Crizotinib—lung cancer	0.00547	0.00569	CcSEcCtD
Bretylium—Lightheadedness—Docetaxel—lung cancer	0.00536	0.00558	CcSEcCtD
Bretylium—Sweating increased—Irinotecan—lung cancer	0.0053	0.00551	CcSEcCtD
Bretylium—Angina pectoris—Irinotecan—lung cancer	0.0053	0.00551	CcSEcCtD
Bretylium—Dizziness—Crizotinib—lung cancer	0.00528	0.0055	CcSEcCtD
Bretylium—Dyspnoea—Teniposide—lung cancer	0.00527	0.00549	CcSEcCtD
Bretylium—Lethargy—Paclitaxel—lung cancer	0.00524	0.00545	CcSEcCtD
Bretylium—Orthostatic hypotension—Cisplatin—lung cancer	0.00522	0.00543	CcSEcCtD
Bretylium—Vomiting—Crizotinib—lung cancer	0.00508	0.00529	CcSEcCtD
Bretylium—Diarrhoea—Pemetrexed—lung cancer	0.005	0.0052	CcSEcCtD
Bretylium—Vertigo—Vinblastine—lung cancer	0.00497	0.00517	CcSEcCtD
Bretylium—Diarrhoea—Gefitinib—lung cancer	0.00496	0.00517	CcSEcCtD
Bretylium—Flushing—Vinorelbine—lung cancer	0.0049	0.0051	CcSEcCtD
Bretylium—Feeling abnormal—Teniposide—lung cancer	0.00487	0.00507	CcSEcCtD
Bretylium—Mood swings—Paclitaxel—lung cancer	0.00486	0.00506	CcSEcCtD
Bretylium—Gastrointestinal pain—Teniposide—lung cancer	0.00484	0.00503	CcSEcCtD
Bretylium—Dizziness—Pemetrexed—lung cancer	0.00483	0.00502	CcSEcCtD
Bretylium—Sweating increased—Cisplatin—lung cancer	0.00481	0.00501	CcSEcCtD
Bretylium—Hypertension—Vinblastine—lung cancer	0.00477	0.00497	CcSEcCtD
Bretylium—Syncope—Erlotinib—lung cancer	0.00477	0.00496	CcSEcCtD
Bretylium—Nausea—Crizotinib—lung cancer	0.00475	0.00494	CcSEcCtD
Bretylium—Orthostatic hypotension—Paclitaxel—lung cancer	0.00469	0.00488	CcSEcCtD
Bretylium—Body temperature increased—Teniposide—lung cancer	0.00467	0.00487	CcSEcCtD
Bretylium—Abdominal pain—Teniposide—lung cancer	0.00467	0.00487	CcSEcCtD
Bretylium—Loss of consciousness—Erlotinib—lung cancer	0.00467	0.00486	CcSEcCtD
Bretylium—Vomiting—Pemetrexed—lung cancer	0.00464	0.00483	CcSEcCtD
Bretylium—Vomiting—Gefitinib—lung cancer	0.00461	0.0048	CcSEcCtD
Bretylium—Anxiety—Erlotinib—lung cancer	0.00451	0.00469	CcSEcCtD
Bretylium—ATP1A1—respiratory system—lung cancer	0.00447	0.114	CbGeAlD
Bretylium—Lethargy—Docetaxel—lung cancer	0.00444	0.00462	CcSEcCtD
Bretylium—Bradycardia—Irinotecan—lung cancer	0.00443	0.00461	CcSEcCtD
Bretylium—Sweating increased—Etoposide—lung cancer	0.00441	0.00459	CcSEcCtD
Bretylium—Nausea—Pemetrexed—lung cancer	0.00434	0.00451	CcSEcCtD
Bretylium—Sweating increased—Paclitaxel—lung cancer	0.00432	0.0045	CcSEcCtD
Bretylium—Nausea—Gefitinib—lung cancer	0.00431	0.00448	CcSEcCtD
Bretylium—Conjunctivitis—Cisplatin—lung cancer	0.00428	0.00445	CcSEcCtD
Bretylium—Shock—Erlotinib—lung cancer	0.00427	0.00444	CcSEcCtD
Bretylium—Hyperhidrosis—Topotecan—lung cancer	0.00424	0.00441	CcSEcCtD
Bretylium—Ventricular extrasystoles—Doxorubicin—lung cancer	0.00414	0.00431	CcSEcCtD
Bretylium—Vertigo—Vinorelbine—lung cancer	0.00413	0.0043	CcSEcCtD
Bretylium—Diarrhoea—Teniposide—lung cancer	0.00405	0.00421	CcSEcCtD
Bretylium—Flushing—Irinotecan—lung cancer	0.00404	0.0042	CcSEcCtD
Bretylium—Bradycardia—Cisplatin—lung cancer	0.00402	0.00419	CcSEcCtD
Bretylium—SLC6A2—respiratory system—lung cancer	0.00398	0.101	CbGeAlD
Bretylium—Orthostatic hypotension—Docetaxel—lung cancer	0.00397	0.00413	CcSEcCtD
Bretylium—Hypertension—Vinorelbine—lung cancer	0.00397	0.00413	CcSEcCtD
Bretylium—Dyspnoea—Topotecan—lung cancer	0.00391	0.00407	CcSEcCtD
Bretylium—Dyspnoea—Erlotinib—lung cancer	0.00387	0.00402	CcSEcCtD
Bretylium—Conjunctivitis—Paclitaxel—lung cancer	0.00384	0.004	CcSEcCtD
Bretylium—Vomiting—Teniposide—lung cancer	0.00376	0.00391	CcSEcCtD
Bretylium—Hiccups—Doxorubicin—lung cancer	0.00374	0.00389	CcSEcCtD
Bretylium—ATP1A1—epithelium—lung cancer	0.00374	0.0955	CbGeAlD
Bretylium—Feeling abnormal—Vinblastine—lung cancer	0.00372	0.00387	CcSEcCtD
Bretylium—Gastrointestinal pain—Vinblastine—lung cancer	0.00369	0.00384	CcSEcCtD
Bretylium—ATP1A1—bronchus—lung cancer	0.00368	0.094	CbGeAlD
Bretylium—Flushing—Cisplatin—lung cancer	0.00367	0.00382	CcSEcCtD
Bretylium—Angina pectoris—Docetaxel—lung cancer	0.00366	0.00381	CcSEcCtD
Bretylium—Bradycardia—Paclitaxel—lung cancer	0.00361	0.00376	CcSEcCtD
Bretylium—Feeling abnormal—Topotecan—lung cancer	0.00361	0.00376	CcSEcCtD
Bretylium—Gastrointestinal pain—Topotecan—lung cancer	0.00358	0.00373	CcSEcCtD
Bretylium—Abdominal pain—Vinblastine—lung cancer	0.00357	0.00371	CcSEcCtD
Bretylium—Gastrointestinal pain—Erlotinib—lung cancer	0.00355	0.00369	CcSEcCtD
Bretylium—Nausea—Teniposide—lung cancer	0.00351	0.00366	CcSEcCtD
Bretylium—Abdominal pain—Topotecan—lung cancer	0.00346	0.00361	CcSEcCtD
Bretylium—Body temperature increased—Topotecan—lung cancer	0.00346	0.00361	CcSEcCtD
Bretylium—Body temperature increased—Erlotinib—lung cancer	0.00343	0.00357	CcSEcCtD
Bretylium—Abdominal pain—Erlotinib—lung cancer	0.00343	0.00357	CcSEcCtD
Bretylium—Vertigo—Irinotecan—lung cancer	0.0034	0.00354	CcSEcCtD
Bretylium—Syncope—Irinotecan—lung cancer	0.0034	0.00354	CcSEcCtD
Bretylium—Flushing—Etoposide—lung cancer	0.00336	0.0035	CcSEcCtD
Bretylium—Dyspnoea—Vinorelbine—lung cancer	0.00334	0.00348	CcSEcCtD
Bretylium—Loss of consciousness—Irinotecan—lung cancer	0.00333	0.00347	CcSEcCtD
Bretylium—ATP1A1—trachea—lung cancer	0.00331	0.0844	CbGeAlD
Bretylium—Flushing—Paclitaxel—lung cancer	0.00329	0.00343	CcSEcCtD
Bretylium—Hypertension—Irinotecan—lung cancer	0.00327	0.0034	CcSEcCtD
Bretylium—Conjunctivitis—Docetaxel—lung cancer	0.00326	0.00339	CcSEcCtD
Bretylium—Lethargy—Methotrexate—lung cancer	0.0032	0.00333	CcSEcCtD
Bretylium—Hypertension—Gemcitabine—lung cancer	0.00319	0.00332	CcSEcCtD
Bretylium—Confusional state—Irinotecan—lung cancer	0.00312	0.00325	CcSEcCtD
Bretylium—ATP1A1—cardiac atrium—lung cancer	0.00311	0.0793	CbGeAlD
Bretylium—Feeling abnormal—Vinorelbine—lung cancer	0.00309	0.00322	CcSEcCtD
Bretylium—Diarrhoea—Vinblastine—lung cancer	0.00309	0.00321	CcSEcCtD
Bretylium—Gastrointestinal pain—Vinorelbine—lung cancer	0.00307	0.00319	CcSEcCtD
Bretylium—Shock—Irinotecan—lung cancer	0.00304	0.00317	CcSEcCtD
Bretylium—Diarrhoea—Topotecan—lung cancer	0.003	0.00312	CcSEcCtD
Bretylium—Hyperhidrosis—Irinotecan—lung cancer	0.00299	0.00311	CcSEcCtD
Bretylium—Dizziness—Vinblastine—lung cancer	0.00298	0.00311	CcSEcCtD
Bretylium—Mood swings—Methotrexate—lung cancer	0.00297	0.00309	CcSEcCtD
Bretylium—Diarrhoea—Erlotinib—lung cancer	0.00297	0.00309	CcSEcCtD
Bretylium—Body temperature increased—Vinorelbine—lung cancer	0.00296	0.00308	CcSEcCtD
Bretylium—Abdominal pain—Vinorelbine—lung cancer	0.00296	0.00308	CcSEcCtD
Bretylium—Anxiety—Cisplatin—lung cancer	0.00292	0.00304	CcSEcCtD
Bretylium—Hyperhidrosis—Gemcitabine—lung cancer	0.00291	0.00303	CcSEcCtD
Bretylium—Dizziness—Topotecan—lung cancer	0.0029	0.00302	CcSEcCtD
Bretylium—Vomiting—Vinblastine—lung cancer	0.00287	0.00299	CcSEcCtD
Bretylium—Dizziness—Erlotinib—lung cancer	0.00287	0.00298	CcSEcCtD
Bretylium—Vertigo—Etoposide—lung cancer	0.00283	0.00295	CcSEcCtD
Bretylium—Flushing—Docetaxel—lung cancer	0.00279	0.00291	CcSEcCtD
Bretylium—Vomiting—Topotecan—lung cancer	0.00279	0.0029	CcSEcCtD
Bretylium—Vertigo—Paclitaxel—lung cancer	0.00278	0.00289	CcSEcCtD
Bretylium—Syncope—Paclitaxel—lung cancer	0.00277	0.00288	CcSEcCtD
Bretylium—Loss of consciousness—Etoposide—lung cancer	0.00277	0.00288	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—lung cancer	0.00277	0.00288	CcSEcCtD
Bretylium—Vomiting—Erlotinib—lung cancer	0.00276	0.00287	CcSEcCtD
Bretylium—Dyspnoea—Irinotecan—lung cancer	0.00276	0.00287	CcSEcCtD
Bretylium—Hypertension—Etoposide—lung cancer	0.00272	0.00283	CcSEcCtD
Bretylium—Loss of consciousness—Paclitaxel—lung cancer	0.00272	0.00283	CcSEcCtD
Bretylium—Hyperhidrosis—Cisplatin—lung cancer	0.00271	0.00282	CcSEcCtD
Bretylium—Dyspnoea—Gemcitabine—lung cancer	0.00269	0.0028	CcSEcCtD
Bretylium—Nausea—Vinblastine—lung cancer	0.00268	0.00279	CcSEcCtD
Bretylium—Affect lability—Doxorubicin—lung cancer	0.00267	0.00278	CcSEcCtD
Bretylium—Hypertension—Paclitaxel—lung cancer	0.00267	0.00278	CcSEcCtD
Bretylium—ATP1A1—bone marrow—lung cancer	0.00262	0.067	CbGeAlD
Bretylium—Anxiety—Paclitaxel—lung cancer	0.00262	0.00273	CcSEcCtD
Bretylium—Nausea—Topotecan—lung cancer	0.0026	0.00271	CcSEcCtD
Bretylium—Confusional state—Etoposide—lung cancer	0.00259	0.0027	CcSEcCtD
Bretylium—Nausea—Erlotinib—lung cancer	0.00258	0.00268	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—lung cancer	0.00257	0.00268	CcSEcCtD
Bretylium—Diarrhoea—Vinorelbine—lung cancer	0.00257	0.00267	CcSEcCtD
Bretylium—Feeling abnormal—Irinotecan—lung cancer	0.00255	0.00265	CcSEcCtD
Bretylium—Confusional state—Paclitaxel—lung cancer	0.00254	0.00265	CcSEcCtD
Bretylium—Gastrointestinal pain—Irinotecan—lung cancer	0.00253	0.00263	CcSEcCtD
Bretylium—Dyspnoea—Cisplatin—lung cancer	0.0025	0.00261	CcSEcCtD
Bretylium—Hyperhidrosis—Etoposide—lung cancer	0.00249	0.00259	CcSEcCtD
Bretylium—Feeling abnormal—Gemcitabine—lung cancer	0.00248	0.00258	CcSEcCtD
Bretylium—Shock—Paclitaxel—lung cancer	0.00248	0.00258	CcSEcCtD
Bretylium—Dizziness—Vinorelbine—lung cancer	0.00248	0.00258	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—lung cancer	0.00248	0.00258	CcSEcCtD
Bretylium—Abdominal pain—Irinotecan—lung cancer	0.00244	0.00254	CcSEcCtD
Bretylium—Body temperature increased—Irinotecan—lung cancer	0.00244	0.00254	CcSEcCtD
Bretylium—Hyperhidrosis—Paclitaxel—lung cancer	0.00244	0.00254	CcSEcCtD
Bretylium—Vomiting—Vinorelbine—lung cancer	0.00238	0.00248	CcSEcCtD
Bretylium—Body temperature increased—Gemcitabine—lung cancer	0.00238	0.00248	CcSEcCtD
Bretylium—ATP1A1—lung—lung cancer	0.00238	0.0607	CbGeAlD
Bretylium—Syncope—Docetaxel—lung cancer	0.00235	0.00244	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—lung cancer	0.00235	0.00244	CcSEcCtD
Bretylium—Feeling abnormal—Cisplatin—lung cancer	0.00231	0.00241	CcSEcCtD
Bretylium—Loss of consciousness—Docetaxel—lung cancer	0.0023	0.0024	CcSEcCtD
Bretylium—Dyspnoea—Etoposide—lung cancer	0.00229	0.00239	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—lung cancer	0.00229	0.00238	CcSEcCtD
Bretylium—Hypertension—Docetaxel—lung cancer	0.00226	0.00235	CcSEcCtD
Bretylium—Dyspnoea—Paclitaxel—lung cancer	0.00225	0.00234	CcSEcCtD
Bretylium—Nausea—Vinorelbine—lung cancer	0.00223	0.00232	CcSEcCtD
Bretylium—Body temperature increased—Cisplatin—lung cancer	0.00222	0.00231	CcSEcCtD
Bretylium—Confusional state—Docetaxel—lung cancer	0.00216	0.00224	CcSEcCtD
Bretylium—Feeling abnormal—Etoposide—lung cancer	0.00212	0.00221	CcSEcCtD
Bretylium—Diarrhoea—Irinotecan—lung cancer	0.00212	0.0022	CcSEcCtD
Bretylium—SLC6A2—lung—lung cancer	0.00211	0.0539	CbGeAlD
Bretylium—Gastrointestinal pain—Etoposide—lung cancer	0.0021	0.00219	CcSEcCtD
Bretylium—Shock—Docetaxel—lung cancer	0.0021	0.00219	CcSEcCtD
Bretylium—Feeling abnormal—Paclitaxel—lung cancer	0.00208	0.00216	CcSEcCtD
Bretylium—Gastrointestinal pain—Paclitaxel—lung cancer	0.00206	0.00215	CcSEcCtD
Bretylium—Diarrhoea—Gemcitabine—lung cancer	0.00206	0.00215	CcSEcCtD
Bretylium—Dizziness—Irinotecan—lung cancer	0.00204	0.00213	CcSEcCtD
Bretylium—Abdominal pain—Etoposide—lung cancer	0.00203	0.00212	CcSEcCtD
Bretylium—Body temperature increased—Etoposide—lung cancer	0.00203	0.00212	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—lung cancer	0.00203	0.00212	CcSEcCtD
Bretylium—Body temperature increased—Paclitaxel—lung cancer	0.00199	0.00207	CcSEcCtD
Bretylium—Abdominal pain—Paclitaxel—lung cancer	0.00199	0.00207	CcSEcCtD
Bretylium—Vomiting—Irinotecan—lung cancer	0.00197	0.00205	CcSEcCtD
Bretylium—Diarrhoea—Cisplatin—lung cancer	0.00192	0.002	CcSEcCtD
Bretylium—Vomiting—Gemcitabine—lung cancer	0.00192	0.00199	CcSEcCtD
Bretylium—Bradycardia—Doxorubicin—lung cancer	0.00191	0.00199	CcSEcCtD
Bretylium—Dyspnoea—Docetaxel—lung cancer	0.00191	0.00198	CcSEcCtD
Bretylium—Nausea—Irinotecan—lung cancer	0.00184	0.00191	CcSEcCtD
Bretylium—Nausea—Gemcitabine—lung cancer	0.00179	0.00186	CcSEcCtD
Bretylium—Vomiting—Cisplatin—lung cancer	0.00179	0.00186	CcSEcCtD
Bretylium—Feeling abnormal—Docetaxel—lung cancer	0.00176	0.00183	CcSEcCtD
Bretylium—Diarrhoea—Etoposide—lung cancer	0.00176	0.00183	CcSEcCtD
Bretylium—Gastrointestinal pain—Docetaxel—lung cancer	0.00175	0.00182	CcSEcCtD
Bretylium—Flushing—Doxorubicin—lung cancer	0.00174	0.00181	CcSEcCtD
Bretylium—Diarrhoea—Paclitaxel—lung cancer	0.00173	0.0018	CcSEcCtD
Bretylium—Dizziness—Etoposide—lung cancer	0.0017	0.00177	CcSEcCtD
Bretylium—Vertigo—Methotrexate—lung cancer	0.0017	0.00177	CcSEcCtD
Bretylium—Abdominal pain—Docetaxel—lung cancer	0.00169	0.00176	CcSEcCtD
Bretylium—Body temperature increased—Docetaxel—lung cancer	0.00169	0.00176	CcSEcCtD
Bretylium—Dizziness—Paclitaxel—lung cancer	0.00167	0.00174	CcSEcCtD
Bretylium—Nausea—Cisplatin—lung cancer	0.00167	0.00174	CcSEcCtD
Bretylium—Vomiting—Etoposide—lung cancer	0.00164	0.0017	CcSEcCtD
Bretylium—ATP1A1—lymph node—lung cancer	0.00162	0.0415	CbGeAlD
Bretylium—Vomiting—Paclitaxel—lung cancer	0.0016	0.00167	CcSEcCtD
Bretylium—Confusional state—Methotrexate—lung cancer	0.00155	0.00162	CcSEcCtD
Bretylium—Nausea—Etoposide—lung cancer	0.00153	0.00159	CcSEcCtD
Bretylium—Nausea—Paclitaxel—lung cancer	0.0015	0.00156	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—lung cancer	0.00149	0.00155	CcSEcCtD
Bretylium—Vertigo—Doxorubicin—lung cancer	0.00147	0.00153	CcSEcCtD
Bretylium—Syncope—Doxorubicin—lung cancer	0.00147	0.00153	CcSEcCtD
Bretylium—Diarrhoea—Docetaxel—lung cancer	0.00146	0.00152	CcSEcCtD
Bretylium—SLC6A2—lymph node—lung cancer	0.00144	0.0369	CbGeAlD
Bretylium—Loss of consciousness—Doxorubicin—lung cancer	0.00144	0.0015	CcSEcCtD
Bretylium—Dizziness—Docetaxel—lung cancer	0.00141	0.00147	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—lung cancer	0.00141	0.00147	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—lung cancer	0.00139	0.00144	CcSEcCtD
Bretylium—Dyspnoea—Methotrexate—lung cancer	0.00137	0.00143	CcSEcCtD
Bretylium—Vomiting—Docetaxel—lung cancer	0.00136	0.00141	CcSEcCtD
Bretylium—Confusional state—Doxorubicin—lung cancer	0.00135	0.0014	CcSEcCtD
Bretylium—Shock—Doxorubicin—lung cancer	0.00131	0.00137	CcSEcCtD
Bretylium—Hyperhidrosis—Doxorubicin—lung cancer	0.00129	0.00134	CcSEcCtD
Bretylium—Nausea—Docetaxel—lung cancer	0.00127	0.00132	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—lung cancer	0.00127	0.00132	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—lung cancer	0.00126	0.00131	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—lung cancer	0.00122	0.00127	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—lung cancer	0.00122	0.00127	CcSEcCtD
Bretylium—Dyspnoea—Doxorubicin—lung cancer	0.00119	0.00124	CcSEcCtD
Bretylium—Feeling abnormal—Doxorubicin—lung cancer	0.0011	0.00114	CcSEcCtD
Bretylium—Gastrointestinal pain—Doxorubicin—lung cancer	0.00109	0.00114	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—lung cancer	0.00105	0.0011	CcSEcCtD
Bretylium—Abdominal pain—Doxorubicin—lung cancer	0.00105	0.0011	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—lung cancer	0.00105	0.0011	CcSEcCtD
Bretylium—Dizziness—Methotrexate—lung cancer	0.00102	0.00106	CcSEcCtD
Bretylium—Vomiting—Methotrexate—lung cancer	0.00098	0.00102	CcSEcCtD
Bretylium—Nausea—Methotrexate—lung cancer	0.000915	0.000952	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—lung cancer	0.000913	0.00095	CcSEcCtD
Bretylium—Dizziness—Doxorubicin—lung cancer	0.000882	0.000918	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—lung cancer	0.000848	0.000883	CcSEcCtD
Bretylium—Nausea—Doxorubicin—lung cancer	0.000792	0.000825	CcSEcCtD
